Article
Decitabine induces change of biological traits in myelodysplastic syndromes via FOXO1 activation
2020-08-01
Abstract excerpt
<h4>Background: </h4> Little is known about the function of tumor suppressor gene Forkhead box 1 (FOXO1) in myelodysplastic syndromes (MDS). The aim of this study was to elucidate the role of FOXO1 through decitabine (DAC) treatment. <h4>Methods: </h4>: Microarray analysis was used to identify differentially expressed genes (DEGs) from 2 MDS cell lines by DAC treatment. WebGestalt was used to perform gene ontology...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1425501e-5ca2-5285-815b-e2e5c7f7bb04
- DOI
- 10.21203/rs.3.rs-48006/v1
